{"nctId":"NCT00434057","briefTitle":"Evaluation of Pigmented Skin Lesions With MelaFind(R) System","startDateStruct":{"date":"2007-01"},"conditions":["Melanoma"],"count":1383,"armGroups":[{"label":"Biopsied Pigmented Skin Lesions","type":"OTHER","interventionNames":["Device: MelaFind(R)"]}],"interventions":[{"name":"MelaFind(R)","otherNames":["MF100","MelaFind Device System","MelaFind Device"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* The lesion is pigmented (i.e., melanin, keratin, blood)\n* Clinical management of the lesion by the examining dermatologist is either biopsy of the lesion in toto, or 3-month follow-up of the lesion\n* The diameter of the pigmented area is between 2 and 22 millimeters\n* The lesion is accessible to the MelaFind hand-held imaging device\n* The patient, or a legally authorized representative, has consented to participate in the study and has signed the Informed Consent Form\n\nExclusion Criteria:\n\n* The patient has a known allergy to isopropyl alcohol\n* The lesion has been previously biopsied, excised, or traumatized\n* The skin is not intact (e.g., open sores, ulcers, bleeding)\n* The lesion is within 1 cm of the eye\n* The lesion is on mucosal surfaces (e.g., lips, genitals)\n* The lesion is on palmar hands\n* The lesion is on plantar feet\n* The lesion is on or under nails\n* The lesion is located on or in an area of visible scarring\n* The lesion contains foreign matter (e.g., tattoo, splinter, marker)","healthyVolunteers":true,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Sensitivity and Specificity","description":"Sensitivity is the fraction of correctly identified cases of melanoma. Specificity is the fraction of correctly identified cases of non-melanoma.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"98.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Biopsy Ratio","description":"Number of lesions bioopsied to melanomas detected","paramType":"NUMBER","dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Exploratory Analyses","description":null,"paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":1383},"commonTop":[]}}}